(Stroke. 1997;28:1170-1173.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan.
Background and Purpose We reviewed surgically treated patients with pediatric moyamoya disease and examined whether vasoreconstructive surgeries reduced the risk of recurrent ischemic attacks and changed overall outcomes in terms of the patients' performance and intellectual status.
Methods Sixty-four hemispheric sides in 34 pediatric moyamoya disease patients who received surgical treatment were examined. We performed superficial temporal artery to middle cerebral artery (STA-MCA) bypass and encephalo-duro-arterio-myo-synangiosis (EDAMS) on 48 sides (combined group) and indirect bypass surgery such as EDAMS on 16 sides (indirect group). These 34 patients were observed postoperatively from 1 to 14 years (mean±SD, 6.6±3.8 years) and were examined for the incidence of recurrent ischemic attack. Of the 34 patients, 23 were followed up for >5 postoperative years, and their overall outcomes in terms of their performance and intellectual status were determined.
Results Perioperative ischemic
events (
2 weeks after surgery) occurred in 5 surgeries (31%) of the
indirect group and in 6 (13%) of the combined group (P=NS).
The incidence of postoperative ischemic events (>2 weeks after
surgery) was significantly reduced in the combined group (10%)
compared with the indirect group (56%; P<.01). Of the 23
patients observed >5 years, 7 patients (30%) were mentally retarded
and regarded as having a fair outcome.
Conclusions Combined surgery (STA-MCA bypass with EDAMS) for pediatric moyamoya disease was effective in reducing the risk of postoperative ischemic attacks compared with indirect surgery. Surgical revascularization may be effective in preventing intellectual deterioration and improving overall outcome.
Key Words: bypass surgery cerebral ischemia child moyamoya disease outcome
This article has been cited by other articles:
![]() |
Y. Mineharu, W. Liu, K. Inoue, N. Matsuura, S. Inoue, K. Takenaka, H. Ikeda, K. Houkin, Y. Takagi, K. Kikuta, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3 Neurology, June 10, 2008; 70(24_Part_2): 2357 - 2363. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Sribnick, M. R. Goldblatt, J. W. Campbell, and J. R. Roberts Moyamoya Disease in a Four-Month-Old: A Case Study Clinical Pediatrics, April 1, 2003; 42(3): 281 - 284. [PDF] |
||||
![]() |
F J Kirkham Stroke in childhood Arch. Dis. Child., July 1, 1999; 81(1): 85 - 89. [Full Text] |
||||
![]() |
D. Chiu, P. Shedden, P. Bratina, and J. C. Grotta Clinical Features of Moyamoya Disease in the United States Stroke, July 1, 1998; 29(7): 1347 - 1351. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |